SCUEL — Japan healthcare data

HomeTherapeutic areas › Antiepileptics

Japan market screening · Therapeutic class

Antiepileptics in Japan

抗てんかん剤 · Japan Standard Commodity Classification

27 molecules in this class are marketed in Japan across 243 products. 12 of those products are not shipping normally today — 4.9% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.

27Molecules
243Marketed products
12Products constrained

Molecules in this class

Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.

MoleculeProducts CompaniesConstrained Supply mix
Levetiracetamレベチラセタム42143
Zonisamideゾニサミド3716
Lacosamideラコサミド3611
Sodium Valproateバルプロ酸ナトリウム2571
Lamotrigineラモトリギン2461
Clonazepamクロナゼパム102
Carbamazepineカルバマゼピン933
Midazolamミダゾラム954
Topiramateトピラマート72
Perampanelペランパネル62
Phenytoinフェニトイン52
Gabapentinガバペンチン41
Perampanel Hydrateペランパネル水和物41
Brivaracetamブリーバラセタム31
Clobazamクロバザム31
Stiripentolスチリペントール31
Acetylpheneturideアセチルフェネトライド21
Ethosuximideエトスクシミド22
Primidoneプリミドン21
Rufinamideルフィナミド21
Sultiameスルチアム21
Ethotoinエトトイン11
Fenfluramine Hydrochlorideフェンフルラミン塩酸塩11
Fosphenytoin Sodium Hydrateホスフェニトインナトリウム水和物11
Phenytoin / Phenobarbitalフェニトイン・フェノバルビタール11
Trimethadioneトリメタジオン11
Vigabatrinビガバトリン11
Normal supply Limited supply Supply suspended

How to read this

Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.

Screening this area in Japan?

Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.

Send an enquiry

Our Database Division replies in English within three business days (Japan time).